Literature DB >> 18818481

Modulation of adenylyl cyclase activity in rat striatal homogenate by dopaminergic receptors.

Argo Vonk1, Reet Reinart, Ago Rinken.   

Abstract

We have characterized the modulation of adenylyl cyclase (AC) activity by ligands of dopaminergic receptors in rat striatal homogenate and compared the results with receptor-ligand binding affinities. Despite the fact that rat striatum contains high level of both dopamine D(1) and D(2) receptors, only the D(1)-specific AC activation by agonists could be determined. All D(1)-receptor agonists (dopamine, dihydrexidine, and A 77636) used were able to increase cAMP accumulation in a concentration-dependent manner, while D(1)-receptor antagonists (SCH23390, SKF83566, and butaclamol) blocked the effects induced by the aforementioned agonists. At the same time, the D(2)-receptor agonist quinpirole and antagonist sulpiride had no effect on cAMP accumulation in striatal homogenate neither on the basal level nor on the activated level of AC, while inhibited [(3)H]raclopride binding to these membranes. Comparing the ligands of the D(1) receptor in modulating the activity of AC and displacing D(1)-receptor-specific radioligand [(3)H]SCH23390 binding revealed that the ligands modulate both of these processes with similar affinities. It indicates that under given experimental conditions, only dopamine D(1)-receptor-mediated stimulation of AC activity can be measured in membrane homogenate of rat striatum, while dopamine D(2)-receptor effects remain fully hidden.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818481     DOI: 10.1254/jphs.08019fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  2 in total

1.  Involvement of µ-Opioid Receptor in Methamphetamine-Induced Behavioral Sensitization.

Authors:  Lu-Tai Tien; Ing-Kang Ho
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

2.  Adaptive gene regulation in the Striatum of RGS9-deficient mice.

Authors:  Kathy Busse; Rainer Strotmann; Karl Strecker; Florian Wegner; Vasudharani Devanathan; Antje Gohla; Torsten Schöneberg; Johannes Schwarz
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.